Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model
Authors:
- James W YockmanJYJames W Yockman
- Minhyung LeeMLMinhyung Lee
- Steven KernSKSteven Kern
- Darin Y FurgesonDFDarin Y Furgeson
- Malavosklish BikramMBMalavosklish Bikram
- Sung Wan KimSKSung Wan Kim
Open Access
- 1 June 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 9 (6) , 829-836
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Camptothecin analogs in malignant gliomas: comparative analysis and characterizationJournal of Neurosurgery, 2003
- Breast Cancer ManagementPharmacoEconomics, 2003
- Cremophor ELEuropean Journal of Cancer, 2001
- Interleukin 12 Gene Therapy of Cancer by Peritumoral Injection of Transduced Autologous Fibroblasts: Outcome of a Phase I StudyHuman Gene Therapy, 2001
- Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanismCancer Gene Therapy, 2000
- Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal TissuesJapanese Journal of Cancer Research, 1998
- Interleukin-12 Overcomes Paclitaxel-Mediated Suppression of T-Cell ProliferationImmunopharmacology and Immunotoxicology, 1998
- PaclitaxelDrugs & Aging, 1998
- Clinical Trials: IL-12 Deaths: Explanation and a PuzzleScience, 1995
- Gegenwärtiger Stand der Chemosensibilitätstestung von TumorenDMW - Deutsche Medizinische Wochenschrift, 1983